PharmaShots | Incisive News in 3 Shots

Subscribe Now

UEG

MFDS Korea Approves Onconic Therapeutics’ JAQBO (Zastaprazan citrate) for Treatment of Gastroesophageal Reflux Disease (GERD) in Adults

MFDS Korea Approves Onconic Therapeutics’ JAQBO (Zastaprazan citrate) for Treatment of Gastroesophageal Reflux Disease (GERD) in A...

April 26, 2024

Regeneron Presents P-III Trial Results of Dupixent (dupilumab) for Eosinophilic Esophagitis in Children Aged 1 to 11 Years at UEG 2022

Regeneron Presents P-III Trial Results of Dupixent (dupilumab) for Eosinophilic Esophagitis in Children Aged 1 to 11 Years at UEG...

October 11, 2022

Janssen Presents P-III (UNIFI) Study Results of Stelara (ustekinumab) for Active Ulcerative Colitis at UEG 2022

Janssen Presents P-III (UNIFI) Study Results of Stelara (ustekinumab) for Active Ulcerative Colitis at UEG 2022

October 11, 2022

Janssen Presents P-IIa (VEGA) PoC Study Results of Guselkumab + Golimumab for Active Ulcerative Colitis at UEG 2022

Janssen Presents P-IIa (VEGA) PoC Study Results of Guselkumab + Golimumab for Active Ulcerative Colitis at UEG 2022

October 10, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us